Screener
West Pharmaceutical Services WST Finance Lease Liabilities (Total)
Finance Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiability.
The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000105770-26-000099
FAQ
- What is West Pharmaceutical Services's finance lease liabilities (total)?
- West Pharmaceutical Services (WST) reported finance lease liabilities (total) of $4.4M in Q2 2026.
- How has West Pharmaceutical Services's finance lease liabilities (total) changed year-over-year?
- West Pharmaceutical Services's finance lease liabilities (total) decreased by 10.2% year-over-year, from $4.9M to $4.4M.
- What does finance lease liabilities (total) mean?
- Finance lease liabilities (total) represent the aggregate present value of all future lease payments for assets where the company assumes substantially all risks and rewards of ownership. This metric reflects the long-term debt-like burden associated with financing infrastructure or equipment through leases. It is a key component of the company's total leverage profile.
Ask your AI about West Pharmaceutical Services's finance lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude